FDA Clears Lilly’s Weekly Insulin Onswik, Challenging Novo’s Awiqli on September 25, 2026 Awiqli basal insulin Diabetes Mellitus, Non-Insulin-Dependent eli lilly Insulin insulin efsitora KwikPen once-weekly Onswik QWINT trials United States Food and Drug Administration +